agilon health, inc. provided revenue guidance for the first quarter ending March 31, 2024. For the quarter, the company expects total revenues of $1,605 million to $1,630 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.575 USD | +7.01% | +10.74% | -56.06% |
May. 09 | Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating | MT |
May. 07 | Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.06% | 2.14B | |
-20.63% | 2.94B | |
-13.32% | 2.93B | |
-37.01% | 269M | |
+5.57% | 233M | |
-41.30% | 174M | |
-35.20% | 110M |
- Stock Market
- Equities
- AGL Stock
- News agilon health, inc.
- Agilon health, inc. Provides Revenue Guidance for the First Quarter Ending March 31, 2024